Percutaneous transluminal coronary angioplasty for acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Internal medicine

• Publication date

  1993-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.32.285PMID 8358117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction.

  1991cited by this paper
• Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

  1991cited by this paper
• Thrombolysis in myocardial Infarction (TIMI) trial–phase I

  1990cited by this paper
• Catheterization laboratory events and hospital outcome with direct angioplasty for acute myocardial infarction.

  1990cited by this paper
• Emergency angioplasty in acute anterior myocardial infarction.

  1989cited by this paper
• Coronary angioplasty immediately after thrombolysis in 115 consecutive patients with acute myocardial infarction.

  1988cited by this paper
• Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.

  1988cited by this paper
• Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty.

  1988cited by this paper
• Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase.

  1988cited by this paper
• Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.

  1988cited by this paper
• Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator.

  1988cited by this paper
• Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.

  1988cited by this paper
• Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

  1987cited by this paper
• A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction.

  1987cited by this paper
• Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate.

  1987cited by this paper
• Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience.

  1987cited by this paper
• Early intervention in acute myocardial infarction: significance for myocardial salvage of immediate intravenous streptokinase therapy followed by coronary angioplasty.

  1987cited by this paper
• A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

  1987cited by this paper
• A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction.

  1986cited by this paper
• Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.

  1986cited by this paper
• Combined thrombolytic therapy and coronary angioplasty for acute myocardial infarction.

  1986cited by this paper
• Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial.

  1986cited by this paper
• Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction: Verstraete M, Bory M, Erbel R, et al Lancet 842–847 Apr 13, 1985

  1985cited by this paper
• Percutaneous transluminal coronary angioplasty in acute myocardial infarction.

  1984cited by this paper
• Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.

  1984cited by this paper
• Percutaneous transluminal coronary angioplasty: application for acute myocardial infarction.

  1984cited by this paper
• Percutaneous Transluminal Coronary Angioplasty Immediately After Intracoronary Streptolysis of Transmural Myocardial Infarction

  1982cited by this paper
• Selective Intracoronary Thrombolysis in Acute Myocardial Infarction and Unstable Angina Pectoris

  1981cited by this paper
• Intracoronary thrombolysis in evolving myocardial infarction.

  1981cited by this paper
• Intracoronary thrombolysis in evolving myocardial infarction.

  1981cited by this paper
• Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

  1980cited by this paper

• Primary mechanical recanalization of occluded coronary arteries without prior thrombolytic therapy in patients with acute myocardial infarction. A single-center study reporting acute results and complications.

  1995cites this paper